Your peptide could be contaminated by the second or third injection
Ardissino D, Merlini PA, Savonitto S et al
Increased Energy Levels: Regular use of InfiniWell BPC RAPID may lead to enhanced energy levels
At MIHA, BPC-157 is administered via subcutaneous injection or oral formulation, depending on your specific treatment goals
Manufacturing, Purity, and Safety Concerns Why manufacturing matters BPC-157 is made using a complex chemical process involving: Synthetic amino acids (Fmoc-protected amino acids) Polymer resins (Rink, Wang, or PAL resin) Aggressive solvents (DMF, DCM) Reactive coupling agents (HATU, HBTU, DIC, PyBOP) Strong acids (TFA) HPLC chemicals and stabilizers In pharmaceutical-grade production, these chemicals are removed to trace levels through validated purification steps and quality control testing
Support team responded to a pre-order question within 2 hours. The TFA residue data on the COA was the deciding factor for us our cell assay protocols are sensitive to TFA contamination
